GSK plans to move vaccine R&D center from Rockville, Maryland, to the Boston area

After calling Rockville, Maryland, home for more than eight years, Big Pharma GSK is planning to move its vaccine and infectious disease R&D teams northeast to Cambridge, Massachusetts, the company confirmed to Fierce Biotech.